Immix Biopharma, Inc. (IMMX)
9.22
+0.22
(+2.44%)
USD |
NASDAQ |
Jun 01, 16:00
9.22
0.00 (0.00%)
After-Hours: 20:00
Immix Biopharma Total Assets (Quarterly) : 95.82M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 17.43M |
| Relay Therapeutics, Inc. | 699.61M |
| Annexon, Inc. | 262.89M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.45M |
| Shareholders Equity (Quarterly) | 84.36M |
| Debt to Equity Ratio | 0.0123 |
| Current Ratio | 8.755 |
| Net Debt Paydown Yield | 0.00% |